Acquisition
Healthcare investor MDY Healthcare plc has agreed to acquire two quoted healthcare investments from the private equity group 3i Group plc for a total of £3 million.
The deal to acquire stakes in ProStrakan plc and Santhera GmbH will be sealed by a combination of cash, new ordinary shares and unsecured loan notes.
At the same time MDY announced that it is in the process of establishing a fund to invest in medtech companies in China, saying it has identified a large and growing demand for mid-range medical devices and equipment in the country.
3i has committed to invest $1 million as a cornerstone investor in MDY Healthcare’s new international business, subject to the finalisation of documentation relating to its structure, and the receipt by 3i from MDY of the £3 million for the ProStrakan and Santhera stakes.
Following completion of the deal 3i will hold 29.9 per cent of MDY’s equity.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
Follow where the public and private R&I money is going and which collaborative opportunities you can pursue.
